Is Tesla Stock Overvalued or a Buy for the Next Decade?
Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…
Buy
57
HALO Quote, Financials, Valuation and Earnings
Last price:
$54.44
Seasonality move
:
2.09%
Day range:
$54.22 - $55.09
52-week range:
$42.01 - $70.51
Dividend yield:
0%
P/E ratio:
14.47x
P/S ratio:
6.46x
P/B ratio:
13.90x
Volume:
2M
Avg. volume:
2.7M
1-year change:
24.19%
Market cap:
$6.7B
Revenue:
$1B
EPS (TTM):
$3.76
Halozyme Therapeutics SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
HALO
Halozyme Therapeutics
|
05/07/2024 | 10-Q | 10-Q filing on 05/07/2024 | View Form |
|
HALO
Halozyme Therapeutics
|
11/06/2023 | 10-Q | 10-Q filing on 11/06/2023 | View Form |
|
HALO
Halozyme Therapeutics
|
08/08/2023 | 10-Q | 10-Q filing on 08/08/2023 | View Form |
|
HALO
Halozyme Therapeutics
|
05/09/2023 | 10-Q | 10-Q filing on 05/09/2023 | View Form |
|
HALO
Halozyme Therapeutics
|
11/08/2022 | 10-Q | 10-Q filing on 11/08/2022 | View Form |
|
HALO
Halozyme Therapeutics
|
08/09/2022 | 10-Q | 10-Q filing on 08/09/2022 | View Form |
|
HALO
Halozyme Therapeutics
|
05/10/2022 | 10-Q | 10-Q filing on 05/10/2022 | View Form |
|
HALO
Halozyme Therapeutics
|
11/02/2021 | 10-Q | 10-Q filing on 11/02/2021 | View Form |
|
HALO
Halozyme Therapeutics
|
08/09/2021 | 10-Q | 10-Q filing on 08/09/2021 | View Form |
|
HALO
Halozyme Therapeutics
|
05/10/2021 | 10-Q | 10-Q filing on 05/10/2021 | View Form |
|
HALO
Halozyme Therapeutics
|
11/02/2020 | 10-Q | 10-Q filing on 11/02/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
08/10/2020 | 10-Q | 10-Q filing on 08/10/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
05/11/2020 | 10-Q | 10-Q filing on 05/11/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
02/24/2020 | 10-K | 10-K filing on 02/24/2020 | View Form |
|
HALO
Halozyme Therapeutics
|
11/12/2019 | 10-Q | 10-Q filing on 11/12/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
08/06/2019 | 10-Q | 10-Q filing on 08/06/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
05/07/2019 | 10-Q | 10-Q filing on 05/07/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
02/21/2019 | 10-K | 10-K filing on 02/21/2019 | View Form |
|
HALO
Halozyme Therapeutics
|
11/06/2018 | 10-Q | 10-Q filing on 11/06/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
08/07/2018 | 10-Q | 10-Q filing on 08/07/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
05/10/2018 | 10-Q | 10-Q filing on 05/10/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
02/20/2018 | 10-K | 10-K filing on 02/20/2018 | View Form |
|
HALO
Halozyme Therapeutics
|
11/07/2017 | 10-Q | 10-Q filing on 11/07/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
08/08/2017 | 10-Q | 10-Q filing on 08/08/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
05/09/2017 | 10-Q | 10-Q filing on 05/09/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
02/28/2017 | 10-K | 10-K filing on 02/28/2017 | View Form |
|
HALO
Halozyme Therapeutics
|
11/07/2016 | 10-Q | 10-Q filing on 11/07/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
08/09/2016 | 10-Q | 10-Q filing on 08/09/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
05/09/2016 | 10-Q | 10-Q filing on 05/09/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
02/29/2016 | 10-K | 10-K filing on 02/29/2016 | View Form |
|
HALO
Halozyme Therapeutics
|
11/09/2015 | 10-Q | 10-Q filing on 11/09/2015 | View Form |
|
HALO
Halozyme Therapeutics
|
08/11/2015 | 10-Q | 10-Q filing on 08/11/2015 | View Form |
|
HALO
Halozyme Therapeutics
|
08/10/2015 | 10-Q | 10-Q filing on 08/10/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Apple Stock Undervalued or Overvalued?
For many years, Apple (NASDAQ:AAPL) was just about the perfect…
Where Will Palo Alto Networks Stock Be in 5 Years?
You know those companies that just refuse to slow down…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
58
TNXP alert for May 28
Tonix Pharmaceuticals Holding [TNXP] is up 1.57% over the past day.
Sell
37
ATS alert for May 29
ATS [ATS] is down 1.27% over the past day.
Buy
88
SMR alert for May 28
NuScale Power [SMR] is down 0.37% over the past day.
